The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Voice Prosthesis After Laryngectomy

Tracheoesophageal speech rehabilitation following total laryngectomy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →

What is Voice Prosthesis After Laryngectomy?

Voice prosthesis or tracheoesophageal voice restoration represents the gold standard for voice rehabilitation following total laryngectomy. The technique uses a small silicone one-way valve placed in a tracheoesophageal puncture (TEP) created surgically between the posterior tracheal wall and anterior esophageal wall. When the patient occludes the tracheostoma during exhalation, pulmonary air is redirected through the prosthesis into the esophagus, vibrating the pharyngoesophageal segment to produce voice (neoglottic vibration).

Indications include patients who have undergone total laryngectomy with anatomically and physiologically appropriate pharyngoesophageal segment, motivated patient with appropriate manual dexterity, no severe pharyngoesophageal stricture, and adequate pulmonary function. Primary TEP is performed during initial laryngectomy surgery, while secondary TEP is performed weeks to months later in selected patients. Contraindications include severe cognitive impairment, inability to manage prosthesis, severe pharyngoesophageal hypertonicity unresponsive to dilation, and uncontrolled tumor recurrence at the puncture site.

Modern indwelling prostheses (Provox, Blom-Singer) typically last 3-6 months before requiring replacement due to candidal biofilm formation, valve incompetence, or leakage. Speech outcomes are excellent with 80-90% success rates, fluent intelligible speech production, near-normal speaking rate and rhythm, and significant quality-of-life improvement. Complications include device aspiration, leakage causing aspiration pneumonia, granulation tissue formation, fistula enlargement, and biofilm formation requiring frequent prosthesis change.

Symptoms

Status post total laryngectomy
Inability to produce voice
Speech and communication impairment
Quality-of-life impairment from communication loss
Dependence on alternative communication methods (writing, electrolarynx)
Patient motivation for voice restoration
Adequate pulmonary function
Manual dexterity for prosthesis management
Absence of severe pharyngoesophageal stricture
Patient and family support availability
Appropriate cognitive function for self-care
Postoperative aspiration risk if existing prosthesis leaking
Recurrent pneumonias from prosthesis leakage
Voice quality changes (gurgling, breathy)
Difficulty producing sounds at certain frequencies
Vocal fatigue with extended speaking
Frequent prosthesis replacement need (monthly or shorter)
Granulation tissue at puncture site
Fistula widening over time
Biofilm formation on prosthesis

Risk Factors

Severe pharyngoesophageal stricture
Pharyngoesophageal hypertonicity
Severe cognitive impairment limiting self-care
Compromised manual dexterity
Active or recurrent tumor at puncture site
Severe radiation effects on tissues
Compromised pulmonary function
Diabetes mellitus uncontrolled
Smoking
Active infection
Severely compromised tissue healing
Anticoagulation therapy
Compromised vascular supply
Patient noncompliance with care regimen
Limited support from family or caregivers
Severe gastroesophageal reflux disease
Concurrent chemotherapy
Complicated surgical anatomy
Prior failed voice restoration attempts
Compromised psychological adaptation

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Status post total laryngectomy
  • Inability to produce voice after laryngectomy
  • Considering voice restoration options
  • Voice prosthesis leakage symptoms
  • Aspiration with prosthesis use
  • Difficulty producing voice
  • Voice quality deterioration
  • Frequent prosthesis replacement needs
  • Granulation tissue at puncture site
  • Fistula enlargement concerns
  • Concerns about candidal biofilm
  • Recurrent aspiration pneumonia
  • Communication impairment quality-of-life concerns
  • Multidisciplinary rehabilitation interest

Treatment Methods

01
Comprehensive evaluation by laryngologist and speech-language pathologist with TEP expertise
02
Detailed history including laryngectomy type, prior radiation, current voice status
03
Examination of stoma, pharyngoesophageal segment, lung function
04
Insufflation test to assess pharyngoesophageal segment function
05
Modified barium swallow if dysphagia present
06
Consideration of primary versus secondary TEP
07
Patient education on prosthesis care, occlusion technique, voice production
08
Patient training in stoma care, prosthesis cleaning, replacement
09
Surgical TEP creation between tracheal and esophageal walls (primary or secondary)
10
Voice prosthesis insertion (Provox, Blom-Singer) at TEP site
11
Initial speech therapy for voice production training
12
Stoma button or hands-free valve provision
13
Pharyngoesophageal segment dilation if hypertonicity
14
Botulinum toxin injection for refractory hypertonicity
15
Pharyngeal myotomy or selective neurectomy if pharmacologic management fails
16
Patient training in occlusion technique (digital, valve)
17
Speech therapy progression for fluency, articulation, prosody
18
Daily prosthesis cleaning and humidification
19
Heat-moisture exchanger (HME) use for stoma protection
20
Antifungal prophylaxis to reduce candidal biofilm
21
Probiotic dietary supplements consideration
22
Regular prosthesis replacement every 3-6 months
23
Earlier replacement if leakage or valve incompetence
24
Granulation tissue cauterization if present
25
Fistula revision surgery if widening problematic
26
Pulmonary care optimization
27
Multidisciplinary follow-up including ENT, speech therapy, oncology
28
Long-term surveillance for recurrence
29
Quality-of-life assessment at intervals
30
Complication management as needed

Which Department to Visit?

You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About KBB (Kulak Burun Boğaz) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.